Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine in Long COVID
IRCT20220526054990N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluvoxamine in post-COVID syndrome (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoint: Frequency of neuropsychological symptoms of Long COVID syndrome. Started Mar 2022; status: completed.
02
Drugs
fluvoxamine
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on IRCT20220526054990N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220526054990N1.